By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Daxor Corporation 

350 Fifth Avenue, Suite 7120

New York  New York  10118  U.S.A.
Phone: 212-244-0555 Fax: 212-244-0806


Medical Device

Company News
Daxor Corporation (DXR)Announces The Receipt Of A Contract For The Placement Of A BVA-100 Blood Volume Analyzer At Lankenau Medical Center 4/28/2015 11:20:23 AM
Daxor Corporation (DXR) Receives Two Patents, One For Measurement Of Total Body Albumin And A Second Patent For Improved Accuracy Of Blood Volume Measurement 4/9/2015 10:19:22 AM
Daxor Corporation (DXR) Receives Notification Of Patent Approval And Issues An Update On Its Stock Buyback Program 3/17/2015 11:47:17 AM
Daxor Corporation (DXR) Announces Placement Of Two BVA-100 Blood Volume Analyzers 3/13/2015 7:28:29 AM
Daxor Corporation (DXR) Announces Filing Of Form N-CSR For December 31, 2014 3/2/2015 12:42:01 PM
Daxor Corporation (DXR) Announces Major Research Studies 1/30/2015 10:52:49 AM
Daxor Corporation (DXR) Appoints Michael Feldschuh As Executive Vice President 12/18/2014 10:35:22 AM
Daxor Corporation (DXR) Announces A Major Study With The Mayo Clinic 12/11/2014 8:12:08 AM
Daxor Corporation (DXR) Announces Payment Of A Dividend 11/19/2014 5:24:16 PM
Daxor Corporation (DXR) Announces Publication Of A Study Comparing Two Widely Used Surrogate Tests For Estimating Blood Volume With Direct Measurement Of Blood Volume 11/4/2014 12:56:15 PM